Insulating the Bay State Biotech from Headwinds
Dr. Kirk Taylor is Massachusetts’ point person on the life science industry. And he’s just launched a new program with money for biomanufacturing developers
Beacon Hill Must Keep Biotech’s Flywheel Turning
by Banker & Tradesman | Sep 28, 2025
To maintain Massachusetts’ leadership in global drug development, we cannot allow uncertainty and alarm bells coming from its biotech sector to paralyze us.
Most Popular | Most Recent
- Foxborough and World Cup Organizers Reach Agreement Over Security Funding
- Courthouse to Condos Opportunity Coming in Lowell
- 213 Conversions Proposed in DTX, Fort Point Buildings
- Narrowland Group Joins Berkshire Hathaway
- The Gossip Report: March 13, 2026
- Affordability Issues Descend on Rental Market
- Veterinary Drug Firm Leases Offices in Seaport District
- 356 Apartments Proposed Under Healey Fast-Track Review
- Rent Control Opponents Warn of $300B Hit to Local Budgets
- Developer Says Davis Square ‘Needs a Catalyst’: His Proposed Tower
- Courthouse to Condos Opportunity Coming in Lowell 89 views
- The Gossip Report: March 13, 2026 65 views
- 213 Conversions Proposed in DTX, Fort Point Buildings 57 views
- 356 Apartments Proposed Under Healey Fast-Track Review 45 views
- Foxborough and World Cup Organizers Reach Agreement Over Security Funding 26 views
- Narrowland Group Joins Berkshire Hathaway 19 views
- Developer Says Davis Square ‘Needs a Catalyst’: His Proposed Tower 18 views
- Gillette Picks South Boston Development as New HQ 16 views
- Affordability Issues Descend on Rental Market 14 views
- Back Bay BID Prospects Strengthen 11 views